# Biochemical Genetics * **Definition:** Biochemical Genetics is the branch of genetics that studies the chemical processes and substances that occur within living organisms, focusing on the relationship between genes and biochemical pathways, and how genetic variations can affect metabolic functions and contribute to diseases. * **Taxonomy:** Specialties / Biochemical Genetics ## News * Selected news on the topic of **Biochemical Genetics**, for healthcare technology leaders * 2.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/23/2025 | [**Strengthening community well-being: The power of collaboration**](https://www.beckershospitalreview.com/strategy/strengthening-community-well-being-the-power-of-collaboration/) | [[Beckers Hospital Review]] | | 4/9/2025 | [**M6P Therapeutics to Host Virtual KOL Event to Discuss the Lysosomal Storage Disorders ...**](https://finance.yahoo.com/news/m6p-therapeutics-host-virtual-kol-120000845.html) | [[Yahoo Finance]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of ...**](https://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 12/31/2024 | [**Precision Medicine Software Market Focused Insights 2024-2029, with Key Player Profiles of Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel and IBM - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241231013633/en/Precision-Medicine-Software-Market-Focused-Insights-2024-2029-with-Key-Player-Profiles-of-Syapse-AccessDX-Laboratory-Fabric-Genomics-Foundation-Medicine-Intel-and-IBM---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/11/2024 | [**Anasens: Appointment of Pierre Fitzgibbon to the Board of Directors - Business Wire**](https://www.businesswire.com/news/home/20241211465784/en/Anasens-Appointment-of-Pierre-Fitzgibbon-to-the-Board-of-Directors) | [[Business Wire]] | | 12/11/2024 | [**Anasens: Appointment of Pierre Fitzgibbon to the Board of Directors**](https://www.businesswire.com/news/home/20241211465784/en/Anasens-Appointment-of-Pierre-Fitzgibbon-to-the-Board-of-Directors/) | [[Business Wire]] | | 11/26/2024 | [**Mount Sinai leans into AI with new research center - Healthcare Finance News**](https://www.healthcarefinancenews.com/news/mount-sinai-leans-ai-new-research-center) | [[Healthcare Finance]] | | 11/26/2024 | [**Mount Sinai Center to Combine AI, Data Science, Genomics - Healthcare Innovation**](https://www.hcinnovationgroup.com/analytics-ai/artifical-intelligence-machine-learning/news/55246083/mount-sinai-center-to-combine-ai-data-science-genomics) | [[Healthcare Innovation]] | | 11/25/2024 | [**Mount Sinai Health announces new Center for AI and Human Health - Healthcare IT News**](https://www.healthcareitnews.com/news/mount-sinai-health-announces-new-center-ai-and-human-health) | [[Healthcare IT News]] | | 11/25/2024 | [**Hamilton and Amabel James Center for AI and Human Health launches at Mount Sinai**](https://www.news-medical.net/news/20241125/Hamilton-and-Amabel-James-Center-for-AI-and-Human-Health-launches-at-Mount-Sinai.aspx) | [[News Medical Net]] | | 11/25/2024 | [**Mount Sinai Opens the Hamilton and Amabel James Center for Artificial Intelligence and ...**](https://markets.businessinsider.com/news/stocks/mount-sinai-opens-the-hamilton-and-amabel-james-center-for-artificial-intelligence-and-human-health-to-transform-health-care-by-spearheading-the-ai-revolution-1034062543) | [[Business Insider Markets]] | | 11/25/2024 | [**Digi-Tech Pharma & AI Conference 2025: AI and Genomics Take Center Stage (London ...**](https://www.marketwatch.com/press-release/digi-tech-pharma-ai-conference-2025-ai-and-genomics-take-center-stage-london-united-kingdom-may-28-29-2025-researchandmarkets-com-2a20b074) | [[MarketWatch]] | | 11/11/2024 | [**Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028 ...**](https://www.prnewswire.com/news-releases/population-health-management-market-to-grow-by-usd-22-55-billion-from-2024-2028--driven-by-rising-adoption-of-healthcare-it-report-with-ai-impact-on-trends---technavio-302300769.html) | [[PR Newswire]] | | 11/8/2024 | [**AI-driven precision healthcare is here - what you need to know**](https://www.healthcareitnews.com/news/ai-driven-precision-healthcare-here-what-you-need-know) | [[Healthcare IT News]] | | 11/7/2024 | [**Next-Generation Sequencing (NGS) Services Market is expected to generate a revenue of ...**](https://www.prnewswire.com/news-releases/next-generation-sequencing-ngs-services-market-is-expected-to-generate-a-revenue-of-usd-18-35-billion-by-2031--globally-at-21-25-cagr-verified-market-research-302298672.html) | [[PR Newswire]] | | 10/30/2024 | [**Overcoming Barriers to Generative AI in Life Sciences R**](https://www.fiercebiotech.com/sponsored/overcoming-barriers-generative-ai-life-sciences-rd) | [[FierceBiotech]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals) | [[Business Wire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics' Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals**](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/7/2024 | [**Curbside Consult with Dr. Jayne 10/7/24**](https://histalk2.com/2024/10/07/curbside-consult-with-dr-jayne-10-7-24/) | [[HISTalk]] | | 7/30/2024 | [**3Aware Welcomes Prashant Thumma as First Chief Technology Officer - Newswire**](https://www.newswire.com/news/3aware-welcomes-prashant-thumma-as-first-chief-technology-officer-22394217) | [[Newswire]] | | 7/29/2024 | [**3Aware Welcomes Prashant Thumma as First Chief Technology Officer**](https://finance.yahoo.com/news/3aware-welcomes-prashant-thumma-first-100000112.html) | [[Yahoo Finance]] | | 7/22/2024 | [**Robert T. Braithwaite, Channing Hamlet and Daniel A. Platt Share Insights on ... - Los Angeles Times**](https://www.latimes.com/business-insights/story/2024-07-22/robert-t-braithwaite-channing-hamlet-and-daniel-a-platt-share-insights-on-the-healthcare-biotech-and-life-sciences-landscape-in-2024) | [[LA Times]] | | 7/18/2024 | [**Texas A&M Health Teams With BurstIQ to Improve Genomic Research Data Governance**](https://www.pharmexec.com/view/texas-a-m-health-burstiq-genomic-data-governance) | [[PharmExec]] | | 6/26/2024 | [**Life Sciences IT Market Analysis 2024-2033: Size, Share, Trends, And Competitive Landscape**](https://menafn.com/1108378831/Life-Sciences-IT-Market-Analysis-2024-2033-Size-Share-Trends-And-Competitive-Landscape) | menafn.com | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **CS Genetics**: A company focused on single-cell genomics technology. - **Genomics plc**: A company focused on applying genetics in healthcare, enhancing patient outcomes through genomic insights. - **GeneDx**: A company providing access to deidentified genetic data to enhance drug development processes. - **Beckman Coulter Life Sciences**: A leader in laboratory automation, focusing on innovations in genomic sample preparation. - **Labcorp**: A global leader in laboratory services, enhancing genetic testing solutions through acquisitions. - **Cofactor Genomics**: A clinical-stage diagnostics company utilizing RNA decoding to bridge the precision medicine gap. - **Chroma Medicine**: A company developing genomic medicines utilizing epigenetics for precise gene regulation. - **ERS Genomics**: A company holding a significant patent portfolio for CRISPR technology, facilitating research collaborations. - **BioLizard**: A bioinformatics and data engineering company providing advanced analytics solutions for life sciences. - **Illumina**: Pioneering advancements in genome sequencing technology, significantly reducing costs and enhancing genetic analysis capabilities. - **MGI Tech**: Provider of next-generation genomic sequencing technologies aimed at enhancing scientific research and personalized medicine. - **DNAnexus**: A cloud-based platform enhancing biomedical research and precision medicine. - **Genoks**: A company specializing in genomics, collaborating with Velsera to enhance cancer diagnostics. - **Christian Happi**: Distinguished Professor of Molecular Biology and Genomics at Redeemer's University, Nigeria, known for establishing Nigeria's first molecular diagnostic for Lassa fever and founding the African Centre of Excellence for Genomics and Infectious Disease. - **Myriad Genetics**: A genetic testing company integrating its MyRisk Hereditary Cancer Test into Flatiron's OncoEMR platform. - **Pfizer**: A leading pharmaceutical company leveraging AI and cloud computing for genomic analysis and drug discovery. - **Atsena Therapeutics**: A biotechnology company focused on developing innovative gene therapies for inherited retinal diseases. - **Mayo Clinic**: Known for developing digital tools that integrate personalized medical data into electronic health records, enhancing precision medicine. - **Mount Sinai Health System**: A prominent institution integrating AI with genomics and data science to revolutionize healthcare delivery and patient care. ### Partnerships and Collaborations - **GeneDx and biopharmaceutical companies**: Collaborating to improve patient access to genetic testing and expedite treatment development. - **DNAnexus and Galatea Bio**: Strategic collaboration to enhance access to advanced genetic tools for underserved populations. - **Cofactor Genomics and Dr. Howard McLeod**: Collaboration to advance precision medicine solutions through RNA modeling. - **Nano Life Science Institute**: Collaborative research on biosensor technology for detecting biomarkers, enhancing diagnostic capabilities. - **Eli Lilly and Genetic Leap**: Partnership to develop genetic medicine therapeutics using RNA-targeted AI technology. - **Labcorp and Invitae**: Acquisition to enhance genetic testing capabilities for oncology and rare diseases. - **DNAnexus and Discovery Life Sciences**: Working together to improve precision health data analysis through AI-driven solutions. - **Myriad Genetics and Flatiron Health**: Integrating MyRisk testing into OncoEMR to streamline hereditary cancer testing. - **Texas A&M Health and BurstIQ**: Partnering to enhance genomic data governance through the LifeGraph management platform. - **Genoks and Velsera**: Collaborating to enhance cancer diagnostics and treatment in Turkey through advanced genomic analysis. - **MGI Tech and Universidad de San Martín de Porres**: Collaboration to implement advanced genomic sequencing for large-scale studies of human genomes and genetic risk factors. - **University of Plymouth and Children's Tumor Foundation**: Collaborating on a project to develop a humanized meningioma model for research. - **Truvian Health**: Aiming to revolutionize healthcare with a blood testing platform that enhances accessibility and accuracy in lab results. - **Sphere Fluidics and Dr. Alex Dickinson**: Strategic initiative to enhance commercial development and R&D in life sciences. - **GE HealthCare and Mayo Clinic**: Collaborating on AI-driven tools to enhance clinical workflows and integrate personalized data into healthcare systems. - **Microsoft and Providence**: Working together to develop multimodal medical imaging models that streamline healthcare data analysis. - **Mount Sinai and Hasso Plattner Institute**: Partnering to enhance capabilities in AI and data science for improved healthcare outcomes. ### Innovations, Trends, and Initiatives - **CRISPR Technology**: Enabling precise gene editing to treat genetic disorders, with significant implications for biochemical genetics. - **EvoMG Program**: A joint program on evolutionary medical genomics to enhance understanding of disease mechanisms. - **EpiSign Technology**: Developed by researchers to diagnose over 100 genetic diseases through epigenome measurement. - **Newborn Screening Programs**: Integrating genome sequencing to improve early diagnosis and treatment of rare genetic disorders, enhancing outcomes for conditions like Krabbe disease. - **CS Genetics' Instrument-Free Platform**: Innovative platform for single-cell genomics enhancing accessibility and scalability. - **Bioinformatics Solutions**: Emerging platforms like VarSome Clinical are automating the interpretation of NGS data, complying with new EU regulations to ensure safety and effectiveness in clinical genomics. - **Genome Editing Technologies**: Significant advancements in CRISPR and gene therapy technologies are revolutionizing treatments for genetic disorders. - **Next-Generation Sequencing**: Technological advancements in genomic sequencing are facilitating the identification of actionable biomarkers, particularly in oncology. - **GeneDx Discover**: A novel data visualization tool providing biopharmaceutical companies access to deidentified genetic data. - **DNA Synthesis Market**: Experiencing growth due to advancements in genomics and personalized medicine, with a focus on automation and efficiency in gene synthesis processes. - **Next-Generation Sequencing (NGS)**: Advancements in NGS technologies improving accuracy and efficiency in DNA sequencing for personalized medicine. - **Generative AI**: Transforming drug discovery and genomics by analyzing large datasets and automating research tasks. - **Singapore National Precision Medicine Program**: Aiming to sequence 10,000 genomes to understand local genetic diversity and improve disease diagnosis. - **Next-Generation Sequencing (NGS) Services Market**: Projected growth driven by advancements in precision medicine and genomics, with applications in oncology and genetic disease screening. - **Bio|Verse Navigator**: A new dashboard application launched by BioLizard to enhance data exploration and interpretation workflows in biotech and healthcare. - **Cloud-based platforms at Mayo Clinic**: Facilitating secure storage and access to 'omics' data for personalized medicine applications. - **Precision Medicine Software Market Growth**: The market is projected to grow significantly, driven by advancements in genomics and AI, enabling personalized treatment plans. - **Quantum AI**: Combining quantum computing with AI to enhance molecular modeling in drug discovery. - **Hamilton and Amabel James Center at Mount Sinai**: A new facility dedicated to integrating AI with genomics and data science to enhance healthcare delivery. - **AI Innovation Lab by GE HealthCare**: Aims to accelerate AI innovations in medical devices and clinical workflows to improve patient outcomes. ### Challenges and Concerns - **Access to Genetic Testing**: Challenges in ensuring equitable access to genetic testing and treatment options. - **Skilled Personnel Shortage**: A challenge in the genomics sector, impacting the pace of research and development in personalized medicine and genetic therapies. - **High Costs and Accessibility**: Challenges in developing countries regarding the affordability and availability of advanced genomic technologies. - **Data Security in Genomics**: Ensuring the protection of sensitive genomic information is critical, particularly with the integration of blockchain technology. - **Data Security and Standardization**: Concerns regarding the complexity of genomic data and the need for secure handling of sensitive information. - **Data Privacy**: Concerns regarding the security and potential re-identification of de-identified patient data in genomic research. - **Data Security**: Concerns over the security of genomic data as its use in healthcare increases, necessitating robust regulatory frameworks. - **Adoption of Generative AI**: Challenges include mistrust of technology vendors, regulatory concerns, and the need for robust infrastructure in life sciences. - **Training Needs**: Extensive training is required for healthcare professionals to effectively utilize advanced genomic technologies and AI tools. - **Implementation Costs**: High costs and interoperability issues hinder the widespread adoption of precision medicine software, especially in smaller healthcare institutions. - **Data Quality**: Challenges related to the quality of data used in generative AI applications in scientific research. - **Ethical and Regulatory Challenges**: As AI and precision medicine become more prevalent, navigating ethical considerations and regulatory compliance remains a significant concern. - **Ethical Considerations**: The need for transparency in AI decision-making and the implications of using patient data for research. - **FDA Collaboration with Health AI Coalition**: Concerns over potential conflicts of interest due to involvement of major tech companies. - **Integration of AI in Clinical Practice**: The challenge of effectively incorporating AI tools into existing clinical workflows without disrupting patient care. - **Insurance Companies Using AI**: Concerns regarding the denial of coverage based on medical necessity without physician review. - **Patient Consent**: Issues surrounding the complexity of consent forms and patients' understanding of their data rights. ## Related Topics [[Medical Biochemical Genetics]]; [[Clinical Biochemical Genetics]]; [[Laboratory Genetics]]; [[Clinical Genetics]]; [[Medical Genetics]]; [[Molecular Genetic Pathology]]; [[Genetic Pathology]]; [[Molecular Biology]]